Ely Benaim Novo Cure LTD (NVCR) insider trading activity

NVCR Quotes by TradingView

Ely Benaim is Chief Medical Officer of NovoCure Ltd. Currently has a direct ownership of 28,770 shares of NVCR, which is worth approximately $923,517. The most recent transaction as insider was on Mar 03, 2021, when has been sold 3,475 shares (Ordinary Shares) at a price of $150.78 per share, resulting in proceeds of $523,960. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 28.8K
0% 3M change
0% 12M change
Total Value Held $923,517

Ely Benaim Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 03 2021
SELL
Open market or private sale
$523,960 $150.78 p/Share
3,475 Reduced 8.37%
38,065 Ordinary Shares
Mar 03 2021
BUY
Exercise of conversion of derivative security
$241,061 $69.37 p/Share
3,475 Added 7.72%
41,540 Ordinary Shares
Mar 02 2021
BUY
Grant, award, or other acquisition
-
8,709 Added 18.62%
38,065 Restricted Share Units
Dec 21 2020
SELL
Open market or private sale
$389,268 $156.71 p/Share
2,484 Reduced 7.8%
29,356 Ordinary Shares
Dec 21 2020
BUY
Exercise of conversion of derivative security
$162,528 $65.43 p/Share
2,484 Added 7.65%
30,007 Ordinary Shares
EB

Ely Benaim

Chief Medical Officer
Malvern, PA

Track Institutional and Insider Activities on NVCR

Follow NovoCure Ltd and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NVCR shares.

Notify only if

Insider Trading

Get notified when an Novo Cure LTD insider buys or sells NVCR shares.

Notify only if

News

Receive news related to NovoCure Ltd

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NVCR